Progress achieved in the prevention and therapy of Alzheimer's disease
Stähelin, H.B.
Revue Medicale de la Suisse Romande 119(4): 319-322
1999
ISSN/ISBN: 0035-3655 PMID: 10361469 Document Number: 510125
Document emailed within 1 workday
Related Documents
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Utsumi, K. 2014: Progress of dementia medicine: Special reference to Alzheimer's disease Hokkaido Journal of Medical Science 89(1): 21-23
Katayama, T.; Manabe, T.; Tohyama, M. 2003: Recent progress in 'HMGA1a' which causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 61(4): 677-688
Donoso S, A.; Delgado D, C. 2009: Prevention and treatment of Alzheimer disease Revista Medica de Chile 137(2): 289-295
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Touchon, J.; Portet, F.; Gauthier, S. 2006: Prevention trials in Alzheimer disease: one step forward? Neurology 67(9 Suppl 3): S21-S22
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Kitade, H.; Yanagida, H.; Yokoigawa, N.; Yamada, M.; Hijikawa, T.; Kaibori, M.; Matsui, K.; Ishizaki, M.; Yoshioka, K.; Kon, M. 2015: Two Patients with Recurrence of Hepatocellular Carcinoma after Liver Resection Who Achieved Long-Term Stable Disease with Small Doses of Sorafenib Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(7): 863-865
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Asada, T. 2004: Non-pharmacological therapy for Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 72-75
Hara, H. 2004: Vaccine therapy for Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 4): 254-258
Iwatsubo, T. 2002: The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 120(1): 30p-33p
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Hecker, J. 1998: Alzheimer's disease: the advent of effective therapy Australian and New Zealand Journal of Medicine 28(6): 765-771
Geldmacher, D.S. 1997: Donepezil (Aricept) therapy for Alzheimer's disease Comprehensive Therapy 23(7): 492-493